Casadevall, A. and D. A. Relman (2010). “Microbial threat lists: obstacles in the quest for biosecurity?” Nature Reviews Microbiology 8(2): 149-154.
CDC (1974). Classification of Etiologic Agents on the Basis of Hazard. U. S. N. C. D. Center. Atlanta, GA.
CDC (2005). Notification of Exclusion of Attenuated Strains.
CDC/NIH. (2007). “Biosafety in microbiological and biomedical laboratories.” from http://purl. access.gpo.gov/GPO/LPS121160.
Cello, J., A. V. Paul, et al. (2002). “Chemical Synthesis of Poliovirus cDNA: Generation of Infectious Virus in the Absence of Natural Template.” Science 297(5583): 1016-1018.
Chang, J. H., J. M. Urbach, et al. (2005). “A High-Throughput, Near-Saturating Screen for Type III Effector Genes from Pseudomonas syringae.” Proceedings of the National Academy of Sciences of the United States of America 102(7): 2549-2554.
Chang, M. C. Y., R. A. Eachus, et al. (2007). “Engineering Escherichia coli for production of functionalized terpenoids using plant P450s.” Nat Chem Biol 3(5): 274-277.
Commission on the Prevention of WMD Proliferation and Terrorism. (2008). World at Risk : the report of the Commission on the Prevention of WMD Proliferation and Terrorism. New York, Vintage Books.
Couch, B. C., I. Fudal, et al. (2005). “Origins of Host-Specific Populations of the Blast Pathogen Magnaporthe oryzae in Crop Domestication With Subsequent Expansion of Pandemic Clones on Rice and Weeds of Rice.” Genetics 170(2): 613-630.
Damon, I. K. (2007). Genus Orthopoxvirus: Variola virus. Poxviruses: 47-64.
DHHS (1979). “Interstate shipment of etiologic agents; proposed rule.” Federal Register 44(226): 66853-5.
DHHS (1996). 42 CFR Part 72: Additional Requirements for Facilities Transferring or Receiving Select Agents, Federal Register. 61: 55190-55200.
DHHS (2002). Public Health Security and Bioterrorism Preparedness and Response Act of 2002.
DHHS (2005). 42 CFR 72 and 73 and 42 CFR Part 1003: Possession, Use, and Transfer of Select Agents and Toxins; Final Rule, Federal Register. 70: 12294-13325.
DHHS (2009). Screening Framework Guidance for Synthetic Double-Stranded DNA Providers, Federal Register. 74.
DHS (2006). Bioterrorism Risk Assessment. Fort Detrick, MD, Biological Threat Characterization Center of the National Biodefense Analysis and Countermeasures Center.
Dias, M. B., L. Reyes-Gonzalez, et al. (2010). “Effects of the USA PATRIOT ACT and the 2002 Bioterrorism Preparedness Act on select agent research in the United States.” Proceedings of the National Academy of Sciences 107: 9556-9561.
Doolittle, R. (1981). “Similar amino acid sequences: chance or common ancestry?” Science 214(4517): 149-159.
Dunoyer, P., C.-H. Lecellier, et al. (2004). “Probing the MicroRNA and Small Interfering RNA Pathways with Virus-Encoded Suppressors of RNA Silencing.” Plant Cell 16(5): 1235-1250.
Dymond, J. S., L. Z. Scheifele, et al. (2009). “Teaching Synthetic Biology, Bioinformatics and Engineering to Undergraduates: The Interdisciplinary Build-a-Genome Course.” Genetics 181(1): 13-21.
Esposito, J. J., S. A. Sammons, et al. (2006). “Genome Sequence Diversity and Clues to the Evolution of Variola (Smallpox) Virus.” Science: 1125134.
Fallman, M., K. Andersson, et al. (1995). “Yersinia pseudotuberculosis inhibits Fc receptor-mediated phagocytosis in J774 cells.” Infection and Immunity 63(8): 3117-3124.
Fishman, J. A. (2007). “Infection in Solid-Organ Transplant Recipients.” N Engl J Med 357(25): 2601-2614.
Flannagan, R. S., G. Cosio, et al. (2009). ”Antimicrobial mechanisms of phagocytes and bacterial evasion strategies.” Nat Rev Micro 7(5): 355-366.